These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33554821)

  • 1. [Relationship between Changes of Lymphocyte Subsets and Early Hematologic Response in Immunosuppressive Therapy of Severe Aplastic Anemia Patients].
    Li Y; Peng GX; Ye L; Li Y; Li JP; Fan HH; Song L; Yang WR; Yang Y; Zhou K; Zhang L; Jing LP; Zhao X; Zhang FK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):207-212. PubMed ID: 33554821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study.
    Liu Q; Dong H; Li Y; Shen Y; Hong Y; Chen Y; Liu S; Wu X; Liu W; Hu H; Zhao Y; Lin S; Shen Y; Zhou Y; Ye B; Wu D
    Lipids Health Dis; 2022 Oct; 21(1):93. PubMed ID: 36192750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The life span of red blood cell in patients with severe/very severe aplastic anemia].
    Ye L; Guo J; Jing LP; Peng GX; Zhou K; Li Y; Li Y; Li JP; Fan HH; Song L; Zhang FK; Zhang L
    Zhonghua Xue Ye Xue Za Zhi; 2018 Feb; 39(2):137-142. PubMed ID: 29562449
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
    Zhang X; Li Z; Geng W; Song B; Wan C
    Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis-associated aplastic anaemia: clinical characteristics and immunosuppressive therapy outcomes].
    Yang WR; Jing LP; Zhou K; Peng GX; Li Y; Ye L; Li Y; Li JP; Fan HH; Song L; Zhao X; Yang Y; Zhang FK; Zhang L
    Zhonghua Xue Ye Xue Za Zhi; 2016 May; 37(5):399-404. PubMed ID: 27210875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cohort study of immune and hematopoietic functionality changes in severe aplastic anemia patients treated with immunosuppressive therapy.
    Guan J; Sun Y; Fu R; Wang H; Ruan E; Wang X; Qu W; Wang G; Liu H; Wu Y; Song J; Xing L; Li L; Liu H; Liu C; Shao Z
    Medicine (Baltimore); 2019 Jan; 98(3):e14149. PubMed ID: 30653151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of immunosuppressive therapy for severe aplastic anemia patients with absolute neutrophil count of zero.
    Liu J; Lu XY; Cheng L; Yang Y; Lin SY; Yin H; Liu XQ; Wu XM; He GS
    Hematology; 2019 Dec; 24(1):492-497. PubMed ID: 31221029
    [No Abstract]   [Full Text] [Related]  

  • 8. [Analysis of Lymphocyte Subsets in Peripheral Blood of Patients with Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome].
    Lv YF; Yan ZY; Chen NY; Wu JH; Liu B; Wang GL; Wang J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1505-1510. PubMed ID: 27784383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Delayed hematologic response to immunosuppressive therapy in severe aplastic anemia].
    Yang Y; Yang WR; Wu ZJ; Zhao X; Zhang L; Jing LP; Zhou K; Li Y; Peng GX; Li Y; Li JP; Song L; Ye L; Fan HH; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2016 Dec; 37(12):1038-1043. PubMed ID: 28088966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of concentration of cyclosporine A on the early response to immunosuppressive therapy in severe aplastic anemia].
    Liang LY; Zhang L; Jing LP; Zhou K; Wang XD; Li Y; Peng GX; Li Y; Li JP; Shi LH; Ye L; Fan HH; Zhang P; Chu YL; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):766-71. PubMed ID: 22339914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic efficacy evaluation of rabbit anti-thymocyte globulin combined with cyclosporine A in children with aplastic anemia].
    Fu RT; Xue HM; Xu HG; Huang K; Fang JP; Huang SL; Chen C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):426-30. PubMed ID: 23628047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Percentages and functions of natural killer cell subsets in peripheral blood of patients with severe aplastic anemia].
    Li ZS; Shao ZH; Fu R; Wang J; Li LJ; Zhang T; Wang HQ; Wu YH; Ruan EB; Song J; Qu W; Liu H; Xing LM; Wang XM; Liang Y; Guan J; Wang GJ
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1084-7. PubMed ID: 21609587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of pre-immunosupressive therapy iron overload on hematologic response of severe aplastic anemia].
    Ye L; Jing L; Peng G; Zhou K; Li Y; Li Y; Li J; Fan H; Yang W; Zhang F; Zhang L
    Zhonghua Xue Ye Xue Za Zhi; 2016 Apr; 37(4):324-8. PubMed ID: 27093997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of combined immunosuppressive therapy plus umbilical cord blood infusion in severe aplastic anemia patients: A cohort study.
    Luo X; Lu H; Xiu B; Wu H; Li B; Li P; Chen Y; Zhou L; Zhang W; Dong Y; Liang A; Ding Y
    Exp Ther Med; 2018 Feb; 15(2):1966-1974. PubMed ID: 29434791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cells in peripheral blood at diagnosis predict response to immunosuppressive therapy in severe aplastic anemia.
    Yu W; Wang Q; Ge M; Shi X
    Clin Exp Med; 2023 Sep; 23(5):1815-1822. PubMed ID: 36244022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Increasing peripheral blood neutrophils after G-CSF treatment is a predictor of early response to immunosuppressive therapy in severe aplastic anemia].
    Wu Z; Yang W; Zhang L; Jing L; Zhou K; Li Y; Peng G; Ye L; Li Y; Li J; Fan H; Song L; Zhao X; Zhang F
    Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):974-9. PubMed ID: 25417872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial SAA patients benefit from delayed response of IST.
    Wang T; Wang C; Liu C; Shao Z; Fu R
    Front Immunol; 2023; 14():1067977. PubMed ID: 36845107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of immunosuppressive therapy in children with acquired aplastic anemia].
    Wang SC; Zou Y; Chen XJ; Yang WY; Liu TF; Zhang L; Chen YM; Guo Y; Zhu XF
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):53-6. PubMed ID: 19573384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical characteristics of clonal evolution after immunosuppressive therapy in children with severe/very severe aplastic anemia].
    Zhang JL; Liu TF; Chang LX; Chen X; Ren YY; Sun CC; Liu C; An WB; Wan Y; Chen XJ; Yang WY; Wang SC; Guo Y; Zou Y; Chen YM; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jan; 19(1):27-33. PubMed ID: 28100318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia?
    Song MK; Chung JS; Joo YD; Kim YS; Kim SH; Seol YM; Shin HJ; Choi YJ; Cho GJ
    Eur J Haematol; 2009 Jul; 83(1):72-8. PubMed ID: 19220415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.